SPE Workflows for Detecting Nitrosamines in Pharmaceutical Products
Overview of Nitrosamine Contamination Concerns in Pharmaceuticals Nitrosamine contamination has emerged as one of the most significant quality control challenges facing the pharmaceutical industry in recent years. These potentially carcinogenic impurities, formed through reactions between secondary or tertiary amines with nitrosating agents, have been detected in various drug products including angiotensin II receptor blockers (ARBs), […]
SPE Workflows for Detecting Nitrosamines in Pharmaceutical Products Read More »






